Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Cancel

BSE Code : 500257 | NSE Symbol : LUPIN | ISIN : INE326A01037 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

(22-Feb-25 10:41) Lupin gets EIR from USFDA for New Jersey facility
(21-Feb-25 18:12) Lupin receives EIR for its Somerset facility
(19-Feb-25 15:15) Lupin receives 'A-' leadership rating from CDP
(12-Feb-25 11:23) Lupin Q3 PAT climbs 39% YoY to Rs 859 cr
(12-Feb-25 09:05) Board of Lupin approves transfer of OTC consumer healthcare biz to new subsidiary
(12-Feb-25 08:17) Lupin consolidated net profit rises 39.48% in the December 2024 quarter
(10-Feb-25 15:48) Lupin and Natco receives USFDA approval for Bosentan Tablets for Oral Suspension
(05-Feb-25 12:57) Lupin gains on receiving tentative USFDA nod for HIV drug
(03-Feb-25 13:46) Lupin's Somerset -based facility completes US FDA inspection with zero Form 483 observations
(28-Jan-25 10:37) Lupin announces board meeting date

1 2 3 4 5 6 7 8 9 10

Lupin Ltd